Associations of CYP2A6 genotype with smoking behaviors in southern China

被引:44
作者
Liu, Tao [1 ]
David, Sean P. [2 ,3 ,4 ,5 ,6 ]
Tyndale, Rachel F. [7 ,8 ,9 ]
Wang, Hui [1 ]
Zhou, Qian [7 ,8 ,9 ]
Ding, Peng [1 ]
He, Yan-Hui [1 ]
Yu, Xue-Qing [10 ]
Chen, Wei [10 ]
Crump, Casey [2 ,3 ]
Wen, Xiao-Zhong [11 ]
Chen, Wei-Qing [1 ]
机构
[1] Sun Yat Sen Univ, Sch Publ Hlth, Dept Biostat & Epidemiol, Guangzhou 510080, Guangdong, Peoples R China
[2] Stanford Univ, Ctr Educ Family & Community Med, Stanford, CA 94305 USA
[3] Stanford Univ, Div Family & Community Med, Stanford, CA 94305 USA
[4] SRI Int, Menlo Pk, CA 94025 USA
[5] Brown Alpert Med Sch, Ctr Primary Care & Prevent, Pawtucket, RI USA
[6] Brown Alpert Med Sch, Dept Family Med, Pawtucket, RI USA
[7] Univ Toronto, Ctr Addict & Mental Hlth, Toronto, ON, Canada
[8] Univ Toronto, Dept Psychiat, Toronto, ON, Canada
[9] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON, Canada
[10] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Nephrol, Guangzhou 510275, Guangdong, Peoples R China
[11] Brown Univ, Dept Community Hlth, Providence, RI 02912 USA
基金
美国国家卫生研究院;
关键词
Chinese smokers; CYP2A6; genetic polymorphisms; nicotine dependence; smoking cessation; smoking duration; smoking initiation; smoking quantity; SINGLE NUCLEOTIDE POLYMORPHISM; CYTOCHROME-P450; 2A6; CYP2A6; NATIONAL PREVALENCE SURVEY; NICOTINE METABOLITE RATIO; EMERGING TOBACCO HAZARDS; IN-VIVO; TRANSDERMAL NICOTINE; (+)-CIS-3,5-DIMETHYL-2-(3-PYRIDYL)THIAZOLIDIN-4-ONE HYDROCHLORIDE; GENETIC POLYMORPHISMS; ENZYMATIC-ACTIVITY;
D O I
10.1111/j.1360-0443.2010.03353.x
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Aims To investigate the association of CYP2A6 genetic polymorphisms with smoking-related phenotypes in Chinese smokers. Design Case-only genetic association study. Setting Southern China. Participants A total of 1328 Han Chinese smokers who participated in a community-based chronic disease screening project in Guangzhou and Zhuhai from 2006 to 2007. Measurements All participants answered a structured questionnaire about socio-demographic status and smoking behaviors and informative alleles were genotyped for the cytochrome P450 2A6 (CYP2A6) gene (CYP2A6 *4, *5, *7, *9 and *10). Findings The frequencies of CYP2A6 *4, *5, *7, *9 and *10 alleles were 8.5, 1.2, 6.3, 13.5 and 2.4%, which corresponded to 48.9, 15.4, 24.2 and 11.5% of participants being classified as normal, intermediate, slow and poor metabolizers, respectively. Multivariate analyses in male smokers demonstrated that compared with normal metabolizers, poor metabolizers reported smoking fewer cigarettes per day [adjusted odds ratio (OR) = 0.49; 95% confidence interval (CI): 0.32-0.76], started smoking regularly later in life (adjusted OR = 1.55; 95% CI: 1.06-2.26) and, among former smokers, reported smoking for a shorter duration prior to quitting (adjusted OR = 0.33; 95% CI: 0.12-0.94). However, poor metabolizers were less likely to quit smoking and remain abstinent than normal metabolizers (adjusted OR = 0.54; 95% CI: 0.34-0.86). Conclusions Reduced metabolism function of cytochrome P450 2A6 in smokers appears to be associated with fewer cigarettes smoked, later initiation of smoking regularly, shorter smoking duration and lower likelihood of smoking cessation.
引用
收藏
页码:985 / 994
页数:10
相关论文
共 50 条
[21]   The influence of CYP2A6 polymorphisms and cadmium on nicotine metabolism in Thai population [J].
Apinan, Roongnapa ;
Tassaneeyakul, Wichittra ;
Mahavorasirikul, Wiratchanee ;
Satarug, Soisangwang ;
Kajanawart, Sirimas ;
Vannaprasaht, Suda ;
Ruenweerayut, Ronnatrai ;
Na-Bangchang, Kesara .
ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY, 2009, 28 (03) :420-424
[22]   Sequence variants at CHRNB3-CHRNA6 and CYP2A6 affect smoking behavior [J].
Thorgeirsson, Thorgeir E. ;
Gudbjartsson, Daniel F. ;
Surakka, Ida ;
Vink, Jacqueline M. ;
Amin, Najaf ;
Geller, Frank ;
Sulem, Patrick ;
Rafnar, Thorunn ;
Esko, Tonu ;
Walter, Stefan ;
Gieger, Christian ;
Rawal, Rajesh ;
Mangino, Massimo ;
Prokopenko, Inga ;
Magi, Reedik ;
Keskitalo, Kaisu ;
Gudjonsdottir, Iris H. ;
Gretarsdottir, Solveig ;
Stefansson, Hreinn ;
Thompson, John R. ;
Aulchenko, Yurii S. ;
Nelis, Mari ;
Aben, Katja K. ;
den Heijer, Martin ;
Dirksen, Asger ;
Ashraf, Haseem ;
Soranzo, Nicole ;
Valdes, Ana M. ;
Steves, Claire ;
Uitterlinden, Andre G. ;
Hofman, Albert ;
Tonjes, Anke ;
Kovacs, Peter ;
Hottenga, Jouke Jan ;
Willemsen, Gonneke ;
Vogelzangs, Nicole ;
Doering, Angela ;
Dahmen, Norbert ;
Nitz, Barbara ;
Pergadia, Michele L. ;
Saez, Berta ;
De Diego, Veronica ;
Lezcano, Victoria ;
Garcia-Prats, Maria D. ;
Ripatti, Samuli ;
Perola, Markus ;
Kettunen, Johannes ;
Hartikainen, Anna-Liisa ;
Pouta, Anneli ;
Laitinen, Jaana .
NATURE GENETICS, 2010, 42 (05) :448-U135
[23]   CYP2A6 Genotype but not Age Determines Cotinine Half-Life in Infants and Children [J].
Dempsey, D. A. ;
Sambol, N. C. ;
Jacob, P., III ;
Hoffmann, E. ;
Tyndale, R. F. ;
Fuentes-Afflick, E. ;
Benowitz, N. L. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 94 (03) :400-406
[24]   CYP2A6 genotyping methods and strategies using real-time and end point PCR platforms [J].
Wassenaar, Catherine A. ;
Zhou, Qian ;
Tyndale, Rachel F. .
PHARMACOGENOMICS, 2016, 17 (02) :147-162
[25]   Evaluation of a weighted genetic risk score for the prediction of biomarkers of CYP2A6 activity [J].
El-Boraie, Ahmed ;
Taghavi, Taraneh ;
Chenoweth, Meghan J. ;
Fukunaga, Koya ;
Mushiroda, Taisei ;
Kubo, Michiaki ;
Lerman, Caryn ;
Nollen, Nicole L. ;
Benowitz, Neal L. ;
Tyndale, Rachel F. .
ADDICTION BIOLOGY, 2020, 25 (01)
[26]   Relationship Between CYP2A6 and CHRNA5-CHRNA3-CHRNB4 Variation and Smoking Behaviors and Lung Cancer Risk [J].
Wassenaar, Catherine A. ;
Dong, Qiong ;
Wei, Qingyi ;
Amos, Christopher I. ;
Spitz, Margaret R. ;
Tyndale, Rachel F. .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2011, 103 (17) :1342-1346
[27]   Effect of genotype and methylation of CYP2D6 on smoking behaviour [J].
Tiili, Emmi M. ;
Antikainen, Miia S. H. ;
Mitiushkina, Natalia V. ;
Sukhovskaya, Olga A. ;
Imyanitov, Evgeny N. ;
Hirvonen, Ari P. .
PHARMACOGENETICS AND GENOMICS, 2015, 25 (11) :531-540
[28]   Functional characterization of novel rare CYP2A6 variants and potential implications for clinical outcomes [J].
El-Boraie, Ahmed ;
Tanner, Julie-Anne ;
Zhu, Andy Z. X. ;
Claw, Katrina G. ;
Prasad, Bhagwat ;
Schuetz, Erin G. ;
Thummel, Kenneth E. ;
Fukunaga, Koya ;
Mushiroda, Taisei ;
Kubo, Michiaki ;
Benowitz, Neal L. ;
Lerman, Caryn ;
Tyndale, Rachel F. .
CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2022, 15 (01) :204-220
[29]   Genetic polymorphisms and phenotypic analysis of CYP2A6 in the Sherpa population [J].
He, Xue ;
Sun, Fang ;
Zhang, Ning ;
Zhu, Xikai ;
Ma, Lifeng ;
Zhang, Xiyang ;
Zhang, Yuan ;
Kang, Longli ;
Jin, Tianbo ;
Yuan, Dongya .
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (10) :10474-10482
[30]   Influence of CYP2A6 Genetic Variation, Nicotine Dependence Severity, and Treatment on Smoking Cessation Success [J].
Chenoweth, Meghan J. ;
Lerman, Caryn ;
Knight, Jo ;
Tyndale, Rachel F. .
NICOTINE & TOBACCO RESEARCH, 2023, 25 (06) :1207-1211